Meeting
2023 ASCO Annual Meeting
Twenty-one gene recurrence scores in individuals with breast cancer associated with CHEK2 and ATM germline pathogenic variants.
Authors
Payal Deepak Shah
University of Pennsylvania, Philadelphia, PA
Payal Deepak Shah , Jamie Brower , Lauren Cuff , Robert Richardville , Jada G. Hamilton , Judy Ellen Garber , Siddhartha Yadav , Fergus Couch , Kenneth Offit , Susan M. Domchek , Mark E. Robson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10585)
DOI
10.1200/JCO.2023.41.16_suppl.10585
Abstract #
10585
Poster Bd #
218
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Utility of multi-gene panel-based germline analysis following genomic profiling and cascade testing in advanced solid tumors: An initial report of the BRANCH study.
First Author: Takeshi Kuwata
Poster
2017 Genitourinary Cancers Symposium
Inherited pathologic mutations and family history in patients with prostate cancer.
First Author: Shuwen Lin
Poster
2023 ASCO Annual Meeting
HRD signature and HRD genomic landscape of tumors from 896 patients with early-stage breast cancer (BC).
First Author: June Evelyn Jeon
Poster
2023 ASCO Annual Meeting
Integrated clinical, pathologic, and genetic data in a racially diverse hereditary breast cancer cohort.
First Author: Kenna Noel Koehler